Skip to main content
Premium Trial:

Request an Annual Quote

Response Genetics Receives NYS Approval for Cancer Test

NEW YORK (GenomeWeb) – The New York State Department of Health has approved Response Genetics to market and report results from its ResponseDX tests to residents of the state, the company said today. 

The New York approval follows a two-day inspection of Response Genetics' CLIA laboratory in September. 

The company offers ResponseDX Biomarker tests for various cancer types, including lung, breast, and colon cancer. The tests use different technologies such as sequencing, PCR, and fluorescence in situ hybridization. Response Genetics also offers the microarray-based ResponseDX: Tissue of Origin Test for identifying challenging tumors, such as metastatic, poorly differentiated, and undifferentiated cancer. 

Response Genetics acquired the test when it bought the assets of Pathwork Diagnostics in 2013. 

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.